PURPOSE: To assess the value of an abnormal fluorescein dye disappearance test (FDDT), lacrimal syringing, and Jones test for patients with epiphora who are clinically patent to syringing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback